Research ExplorerPublicationsThe Use of PDX1 DNA Methylation to Distinguish Two Subtypes ...

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

Standard

The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses. / Ungefroren, Hendrik; Konukiewitz, Björn; Wellner, Ulrich F; Schrader, Jörg; Keck, Tobias.

In: CANCERS, Vol. 15, No. 1, 160, 27.12.2022.

Research output: SCORING: Contribution to journal › Editorial › Research

Harvard

Ungefroren, H, Konukiewitz, B, Wellner, UF, Schrader, J & Keck, T 2022, 'The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses', CANCERS, vol. 15, no. 1, 160. https://doi.org/10.3390/cancers15010160

APA

Ungefroren, H., Konukiewitz, B., Wellner, U. F., Schrader, J., & Keck, T. (2022). The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses. CANCERS, 15(1), [160]. https://doi.org/10.3390/cancers15010160

Vancouver

Ungefroren H, Konukiewitz B, Wellner UF, Schrader J, Keck T. The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses. CANCERS. 2022 Dec 27;15(1). 160. https://doi.org/10.3390/cancers15010160

Bibtex

@article{6af2b8d03c41496f8b6df65ecb9683e0,
title = "The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses",
abstract = "Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].",
author = "Hendrik Ungefroren and Bj{\"o}rn Konukiewitz and Wellner, {Ulrich F} and J{\"o}rg Schrader and Tobias Keck",
year = "2022",
month = dec,
day = "27",
doi = "10.3390/cancers15010160",
language = "English",
volume = "15",
journal = "CANCERS",
issn = "2072-6694",
publisher = "Multidisciplinary Digital Publishing Institute (MDPI)",
number = "1",

}

RIS

TY - JOUR

T1 - The Use of PDX1 DNA Methylation to Distinguish Two Subtypes of Pancreatic Neuroendocrine Neoplasms with Different Prognoses

AU - Ungefroren, Hendrik

AU - Konukiewitz, Björn

AU - Wellner, Ulrich F

AU - Schrader, Jörg

AU - Keck, Tobias

PY - 2022/12/27

Y1 - 2022/12/27

N2 - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

AB - Pancreatic neuroendocrine neoplasms (pNENs) account for approximately 5% of all pancreatic tumors; thus, they constitute the second most common tumor type in the pancreas [...].

U2 - 10.3390/cancers15010160

DO - 10.3390/cancers15010160

M3 - Editorial

C2 - 36612156

VL - 15

JO - CANCERS

JF - CANCERS

SN - 2072-6694

IS - 1

M1 - 160

ER -